Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Report Type

Organization

Disposition

Year

Month

Found 45628 record(s)

Req # A-2024-000935

Adverse Drug Reactions (ADRs). Report numbers: E2B_00465828, 001102591, 001097155.

Organization: Health Canada

331 page(s)
February 2025

Req # A-2024-001010

Adverse Drug Reactions (ADRs). Report numbers: E2B_07142259, E2B_07238200, E2B_07214768, 001088932, E2B_07214773.

Organization: Health Canada

49 page(s)
February 2025

Req # A-2024-001033

Adverse Drug Reactions (ADRs). Report numbers: E2B_07106036, E2B_07274964, 001106563, 001109888, E2B_07203089, E2B_02534436, 001098065, 001100175, E2B_07210682, 001100176.

Organization: Health Canada

340 page(s)
February 2025

Req # A-2024-001089

Adverse Drug Reactions (ADRs). Report numbers: 001092992, 001093996, 001094287, 001094700, 001097476, E2B_07290090, 001094004, 001095389, E2B_07275097.

Organization: Health Canada

55 page(s)
February 2025

Req # A-2024-001138

Adverse Drug Reactions (ADRs). Report numbers: E2B_07169535, E2B_07057286, 001083488, E2B_07437214, 001083486, 001043994,E2B_07134137, E2B_07143979, E2B_06494432, 001084738.

Organization: Health Canada

308 page(s)
February 2025

Req # A-2024-001154

Adverse Drug Reactions (ADRs). Report numbers: E2B_06156234, E2B_02244949, E2B_05634542, E2B_01465889, E2B_05650540, E2B_02515723, E2B_06180779, E2B_06185519, E2B_02944156, E2B_05360214.

Organization: Health Canada

944 page(s)
February 2025

Req # A-2024-001164

Adverse Drug Reaction (ADR). Report number: 001109635.

Organization: Health Canada

19 page(s)
February 2025

Req # A-2024-001195

Adverse Drug Reactions (ADRs) for Prevacid. Report numbers: E2B_07458778, E2B_07470391. ADRs for Mesalamine. Report numbers: 001109635, 001117721. ADRs for Lansoprazole. Report numbers: E2B_07506380, E2B_07449311, 001110287, 001110732, 001125342,…

Organization: Health Canada

638 page(s)
February 2025

Req # A-2024-001207

Adverse Drug Reactions (ADRs). Report numbers: 001112204, 001104622.

Organization: Health Canada

9 page(s)
February 2025

Req # A-2024-001213

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 24-110766-636.

Organization: Health Canada

4 page(s)
February 2025
Date modified: